IFITM6 expression is increased in macrophages of tumor-bearing mice

Oncology Reports

Volumn 25, Issue 2, 2011, Pages 531-536

  Han, Jeong Hye ^a   Lee, Sunyi ^a   Park, Yun Sun ^a   Park, Jeong Su ^a   Kim, Kun Yong ^a   Lim, Jong Seok ^a   Oh, Ki Sook ^a   Yang, Young ^a  

^a Sookmyung Women's University   (South Korea)

Author keywords

Breast cancer; Interferon induced transmembrane protein; Lipopolysaccharides; Macrophages; Toll like receptor

Indexed keywords

CELL SURFACE PROTEIN; LIPOPOLYSACCHARIDE; PROTEIN IFITM1; PROTEIN IFITM6; TOLL LIKE RECEPTOR AGONIST; UNCLASSIFIED DRUG;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BONE MARROW; DRUG ACTIVITY; GENE EXPRESSION; LYMPH NODE; MACROPHAGE; MOUSE; NONHUMAN; PRIORITY JOURNAL; SPLEEN CELL; T LYMPHOCYTE; THYMUS;

ANIMALS; CARCINOMA; CELL LINE, TUMOR; FEMALE; GENE EXPRESSION REGULATION, NEOPLASTIC; MACROPHAGES; MAMMARY NEOPLASMS, ANIMAL; MEMBRANE GLYCOPROTEINS; MEMBRANE PROTEINS; MICE; MICE, INBRED BALB C; MULTIGENE FAMILY; NEOPLASM TRANSPLANTATION; NEOPLASMS; TRANSPLANTATION, ISOGENEIC; UP-REGULATION;

EID: 78651378803     PISSN: 1021335X     EISSN: 17912431     Source Type: Journal    
DOI: 10.3892/or.2010.1092     Document Type: Article

References (15)

1. Reiter Z: Interferon - a major regulator of natural killer cell-mediated cytotoxicity. J Interferon Res 13: 247-257, 1993.
2. Decker T, Muller M and Stockinger S: The yin and yang of type I interferon activity in bacterial infection. Nat Rev Immunol 5: 675-687, 2005.
3. Berenson LS, Ota N and Murphy KM: Issues in T-helper 1 development - resolved and unresolved. Immunol Rev 202: 157-174, 2004.
4. Dunn GP, Koebel CM and Schreiber RD: Interferons, immunity and cancer immunoediting. Nat Rev Immunol 6: 836-848, 2006.
5. Tanaka SS and Matsui Y: Developmentally regulated expression of mil-1 and mil-2, mouse interferon-induced transmembrane protein like genes, during formation and differentiation of primordial germ cells. Mech Dev 119 (Suppl 1): 261-267, 2002.
6. Tanaka SS, Nagamatsu G, Tokitake Y, Kasa M, Tam PP and Matsui Y: Regulation of expression of mouse interferon-induced transmembrane protein like gene-3, Ifitm3 (mil-1, fragilis), in germ cells. Dev Dyn 230: 651-659, 2004.
7. Lewin AR, Reid LE, McMahon M, Stark GR and Kerr IM: Molecular analysis of a human interferon-inducible gene family. Eur J Biochem 199: 417-423, 1991.
8. Ackrill AM, Reid LE, Gilbert CS, et al: Differential response of the human 6-16 and 9-27 genes to alpha and gamma interferons. Nucleic Acids Res 19: 591-598, 1991.
9. Evans SS, Collea RP, Leasure JA and Lee DB: IFN-alpha induces homotypic adhesion and Leu-13 expression in human B lymphoid cells. J Immunol 150: 736-747, 1993. (Pubitemid 23133653)
10. Yang Y, Lee JH, Kim KY, et al: The interferon-inducible 9-27 gene modulates the susceptibility to natural killer cells and the invasiveness of gastric cancer cells. Cancer Lett 221: 191-200, 2005. (Pubitemid 40460406)
11. Yang G, Xu Y, Chen X and Hu G: IFITM1 plays an essential role in the antiproliferative action of interferon-gamma. Oncogene 26: 594-603, 2007. (Pubitemid 46160972)
12. Smith RA, Young J, Weis JJ and Weis JH: Expression of the mouse fragilis gene products in immune cells and association with receptor signaling complexes. Genes Immun 7: 113-121, 2006. (Pubitemid 43336053)
13. Andreu P, Colnot S, Godard C, et al: Identification of the IFITM family as a new molecular marker in human colorectal tumors. Cancer Res 66: 1949-1955, 2006.
14. Varney ML, Johansson SL and Singh RK: Tumour-associated macrophage infiltration, neovascularization and aggressiveness in malignant melanoma: role of monocyte chemotactic protein-1 and vascular endothelial growth factor-A. Melanoma Res 15: 417-425, 2005. (Pubitemid 41558952)
15. Li YM, Baviello G, Vlassara H and Mitsuhashi T: Glycation products in aged thioglycollate medium enhance the elicitation of peritoneal macrophages. J Immunol Methods 201: 183-188, 1997. (Pubitemid 27086715)